All Type of News
Johnson & Johnson made controversy through the pharmacists’ antismoking counseling campaign
Controversy is expected as Johnson & Johnson Korea, selling the antismoking supplement ‘Nicorett’, has contracted a partnership with the Korean Pharmaceutical Association, making a campaign saying ‘Pharmacies will hel...
The ETC drug distribution industry has become the arena of the struggle among multinational companies, given up by domestic distribution companies
Multinational distribution companies and international express carrier companies have actively entered to the ETC drug distribution. On the other hand, as domestic companies and pharmaceutical distribution companies h...
63% of pharmaceutical companies challenging the Exclusive Sale Item Approval have less than KRW 100 billion sales
The Ministry of Food and Drug Safety (Minister Seung-hee Kim) unveiled that 41 pharmaceutical companies applied 134 products for the Exclusive Sale Item Approval in 3 April under the Patent Linkage System enforced in ...
Caduet, the ARB+Statin drug, keeps its indisputable position at the top while Hanmi and Daewoong are chasing
It is known that Pfizer’s Caduet has kept its position at the top in the ARB+Statin drug market, representing hypertension+hyperlipidemia complexes. Then, it is followed by other last movers, such as Hanmi Pharm and D...
Roche Korea spent KRW 7.9 billion to reconstruct almost 20 employees at the end of the last year
It is observed that a Swiss multinational pharmaceutical company, Roche Korea, spent almost KRW 8 billion as ERP (Early Retirement Plan) expenses for a part of its employees.
Roche Korea unveiled through an audit rep...
GSK reorganizes the company on a large scale, including reconstruction of its employeesThe Korean branch of GSK decided to make reorganization of the company on a large scale. In other words, it is creating strategies to adopt the current industrial environment, s...
|
Celgene’s Abraxane INJ extended its indication to lung cancer after pancreatic cancer
Celgene Korea (CEO Ah-kyung Kim), a global pharmaceutical company specializing in cancer, unveiled on the 31st that its ‘Abraxane INJ’ acquired an additional approval to add a non-small cell lung cancer indication fro...
Multinational pharmaceutical companies express “We are trying to make sale alliances, but there is no company to consign”
“It is hard to select a partner in the current circumstance where decent companies already have a number of partnership products.”
Marketers of multinational pharmaceutical companies, preparing launches of new drugs ...
The Nagoya Protocol increases burden on companies
As the Nagoya Protocol, sharing earnings for using foreign natural resources, is enforced, it is expected that domestic companies need to pay royalties worth of 1-3% of sales if a domestic law is ratified.
However, a...
The average medical expense for chronic diseases is monthly KRW 10,500 while man pay KRW 500 more
It is known that monthly medicine expenses for chronic diseases are KRW 10,500 in average.
According to the ‘2012 Basic Analysis Report for the Korea Health Panel (II)’ co-conducted by the National Health Insurance S...
